$PBYI News

Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings

Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00

Puma (PBYI) Q1 2026 Earnings Call Transcript

Puma Biotechnology Q1 Earnings Call Highlights

PBYI Q1 Earnings & Sales Beat Estimates, 2026 Guidance Raised

Puma Biotechnology, Inc. Q1 2026 Earnings Call Summary

Puma Biotechnology, Inc. (PBYI) Q1 2026 Earnings Call Transcript

Puma Biotechnology, Inc. 2026 Q1 - Results - Earnings Call Presentation

PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) Beats Q1 Estimates, Raises Full-Year Guidance

Puma Biotechnology Reports First Quarter 2026 Financial Results

Puma Biotechnology Sees Q2 Sales $52.000M-$55.000M vs $52.000M Est

Puma Biotechnology Raises FY2026 Sales Guidance from $214.000M-$221.000M to $222.000M-$229.000M vs $218.000M Est

Puma Biotechnology Q1 Adj. EPS $(0.04) Beats $(0.13) Estimate, Sales $44.800M Beat $42.000M Estimate

Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results

As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

Puma Biotechnology, Inc. (PBYI) Presents at TD Cowen 46th Annual Health Care Conference - Slideshow

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View